Mary Hatch PhD
Dr. Hatch is an Associate Professor at the Addictions, Drug & Alcohol Institute (ADAI), Department of Psychiatry & Behavioral Sciences, UW School of Medicine. Her research interests are in the development and testing of behavioral and pharmacologic interventions for substance use disorders and HIV prevention. Her work has focused on the intersection of substance use and HIV-related sex and drug use risk behaviors from both the individual and workforce perspectives, and on implementation factors that affect uptake of interventions. She has held multiple and varied roles in research projects since 1994, and has long-standing experience developing, implementing, and overseeing large-scale multi-site clinical trials with community treatment providers. In addition to her work at the University of Washington, Dr. Hatch is a licensed clinical psychologist. She practiced in the community for 17 years and is now at UWMC Outpatient Psychiatry Clinic. Her clinical work specializes in the treatment of drug and alcohol addictions and co-occurring depression, anxiety and trauma.
Dr. Hatch is the Co-Director of the Pacific Northwest Node of the NIDA Clinical Trials Network. She is also the Director of the Clinical Trials Consultation and Technical Assistance Program (C-TAP).
Titles
Associate Professor, Addictions, Drug & Alcohol Institute, Department of Psychiatry & Behavioral Sciences, UW School of Medicine
Multiple PI, Pacific NW Node of the NIDA Clinical Trials Network
Director, Clinical Trials Consultation & Technical Assistance Program
Education
BA, Amherst College
PhD, Clinical Psychology, University of Nebraska-Lincoln
Postdoctoral fellowship at the VA Puget Sound Health Care System’s Center for Excellence in Substance Abuse Treatment and Evaluation (CESATE)
Recent Publications
- Gordon AJ, Hatch MA, Kropp FB, Liebschutz JM, Mooney LJ, Cochran G. Twenty-five years of the NIDA clinical trials network and the future of addiction research. Journal of Substance Use & Addiction Research 2026: 210140 (in press). [doi: 10.1016/j.josat.2026.210140] PMID: 42893770
- Simon CB, Hus C, Prado MG, West II, Kwun CGC, LeMaster JW, Hatch MA, Tong ST, Stephens KA. Examining removal of federal waiver restrictions to prescribing buprenorphine in primary care. Journal of the American Board of Family Medicine 2025;38(3):752-756. [doi: 10.3122/jabfm.2024.240453R1] PMID: 41115754
- Lancaster C, Laschober TC, Nelson CM, Hatch MA, Paschen-Wolff MM, Ertl MM, Wright L, Tross S. Predicting willingness to use MOUD: An application of the theory of reasoned action and theory of planned-behavior. Journal of Drug Issues 2025 (in press). [doi: 10.1177/00220426251395179]
- Orozco K, Laschober TC, Tross S, Ertl MM, Paschen-Wolff MM, Nelson CM, Lancaster C, Hatch MA. Future pandemic preparedness: conceptualizing vaccine willingness in drug-using populations during COVID-19 in Southeastern U.S. cities. Journal of HIV/AIDS & Social Services 2025 (in press). [doi: 10.1080/15381501.2025.2591675]
- Hatch MA, Ertl M, Closs D, Keeshin S, Feinberg J, Orozco K, Tross S. HIV prevention in syringe service programs since the start of COVID-19: Where do we go from here? Current HIV/AIDS Reports 2025;22(1):13. [doi: 10.1007/s11904-024-00721-0] PMID: 39812953 PMCID: PMC12640190
Research Interests
- (Research) Substance use disorder treatment; intersection of substance use and HIV risk; Gender; implementation science.
- (Clinical) Addiction treatment; Comorbidity of depression, anxiety, PTSD and addiction in adults.
Activities
- Co-Director, Pacific Northwest Node of the NIDA Clinical Trials Network of the National Drug Abuse Treatment Clinical Trials Network (NIDA CTN) (2018 – )
- Co-Investigator, NIDA CTN Pacific Northwest Node (2001-2018)
- Consulting Editor: Psychology of Addictive Behaviors, 2020-present
- Member, Comorbidities Special Interest Group, NIDA CTN
- Member, UW/Fred Hutch Center for Aids Research
- Research Mentor, Medical Student Addiction Research Program (MedStar)
- Member, UW/Fred Hutch Center for AIDS Research Substance Use Scientific Working Group
Research & Other Projects
NIDA Clinical Trials Network (CTN), Pacific Northwest Node
Status: current
Training in Equity and Structural Solutions in Addictions
Status: current
Tailoring “Real Men Are Safe” for African American and Hispanic Men
Status: completed
NIDA CTN-0015: Women’s Treatment for Trauma and Substance Use Disorders
Status: completed
NIDA CTN-0030: Prescription Opiate Abuse Treatment Study (POATS)
Status: completed
NIDA CTN-0050: Long-Term Follow-Up of START Patients
Status: completed
